Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

2.61USD
25 Sep 2018
Change (% chg)

$0.11 (+4.40%)
Prev Close
$2.50
Open
$2.53
Day's High
$2.65
Day's Low
$2.53
Volume
57,669
Avg. Vol
118,338
52-wk High
$8.56
52-wk Low
$2.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.85 -0.439
Mar '18 7.55 -0.361
FY 2017 Dec '17 1.12 -0.605
Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 2.30 7.07 1.00 0.85
Quarter Ending Dec-18 6 1.05 1.90 0.50 0.85
Year Ending Dec-18 7 11.56 16.32 10.22 5.75
Year Ending Dec-19 6 21.53 30.40 13.27 15.91
Earnings (per share)
Quarter Ending Sep-18 5 -0.29 -0.17 -0.42 -0.41
Quarter Ending Dec-18 5 -0.31 -0.22 -0.41 -0.39
Year Ending Dec-18 6 -1.38 -1.21 -1.63 -1.86
Year Ending Dec-19 6 -1.15 -0.74 -1.43 -2.17
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) 50.61 114.98 5.74
Price to Book (MRQ) 0.46 15.51 5.00
Price to Tangible Book (MRQ) 6.16 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions 61.24 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.12 411.54 8.01
Sales (TTM) vs TTM 1 Yr. Ago -13.83 80.36 5.64
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.69 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -8.57 -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) 3.77 5.46 3.03
LT Debt to Equity (MRQ) 0.44 35.27 12.51
Total Debt to Equity (MRQ) 0.44 37.09 16.85
Interest Coverage (TTM) -2.14 -102.34 32.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -290.58 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.16
EBITD Margin (TTM) -987.15 -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -991.86 -759.68 4.33
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -1,003.38 -733.53 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -982.39 -734.90 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.40 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) 101,814 23,229,030 860,305,026
Net Income/Employee (TTM) -1,000,203 3,144,146 101,198,978
Receivable Turnover (TTM) 0.73 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) 0.07 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.01 -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -87.80 1.79 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -88.10 3.28 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 24 52
13 Week -20.95 -24.80 19 66
26 Week -24.27 -30.03 26 80
52 Week 15.92 -1.75 61 50
YTD 39.26 22.30 69 61
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 57.09%
# of Holders: 58
Total Shares Held: 37,957,508
3 Mo. Net Change: 7,674,047
# New Positions: 9
# Closed Positions: 13
# Increased Positions: 32
# Reduced Positions: 26
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.